Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway

scientific article published on 12 February 2014

Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TOX.2014.01.008
P698PubMed publication ID24530882
P5875ResearchGate publication ID260168942

P2093author name stringJuan Wang
Xiao Yang
Juan Wu
Xueqing Yu
Wenfang Chen
Xinhui Liu
Youjia Zeng
Jinjin Fan
Xiaorang Feng
P407language of work or nameEnglishQ1860
P921main subjectacute kidney injuryQ424337
P1104number of pages10
P304page(s)22-31
P577publication date2014-02-12
P1433published inToxicologyQ1666328
P1476titleBardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway
P478volume318

Reverse relations

cites work (P2860)
Q38274981Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment
Q36756653Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice
Q53653076Bardoxolone Methyl Prevents Mesenteric Fat Deposition and Inflammation in High-Fat Diet Mice.
Q34415403Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties
Q42704487Curcumin prevents maleate-induced nephrotoxicity: relation to hemodynamic alterations, oxidative stress, mitochondrial oxygen consumption and activity of respiratory complex I.
Q40060254Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.
Q48111922Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study
Q39111132Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury
Q36364169Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney
Q41645053Keap1 hypomorphism protects against ischemic and obstructive kidney disease
Q52668596Kidney disease models: tools to identify mechanisms and potential therapeutic targets.
Q34922961Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2/HO-1 pathway.
Q37343636Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.
Q28384392Oxidant Mechanisms in Renal Injury and Disease
Q47938445PGC1α in the kidney
Q89687493Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt/GSK-3β/Nrf2 Pathway
Q30278441Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments
Q41326070Protective effects of curcumin on acute gentamicin-induced nephrotoxicity in rats
Q52613060Renal aquaporin-4 associated pathology in TG-26 mice.
Q43086271Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver
Q38757482Stop adding insult to injury-identifying and managing risk factors for the progression of acute kidney injury in children

Search more.